Skip to main content
OpenTrials

Clinical trial condition

Poliomyelitis

Explore clinical trials studying Poliomyelitis. Study availability and eligibility vary by location and protocol.

172 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Poliomyelitis trial results

Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site St Austell, Cornwall, United Kingdom
  • GSK Investigational Site Southampton, Hampshire, United Kingdom
  • GSK Investigational Site Axbridge, Somerset, United Kingdom
  • GSK Investigational Site Taunton, Somerset, United Kingdom
View all 13 locations
View Trial Details
Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
  • GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
View all 38 locations
View Trial Details
Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Derval, France
  • GSK Investigational Site La Chapelle-Basse-Mer, France
  • GSK Investigational Site La Riche, France
  • GSK Investigational Site Nantes, France
View all 15 locations
View Trial Details
Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details

Related conditions